Renal cell carcinoma: An update for the practicing urologist

Renal cell carcinoma: An update for the practicing urologist

Systemic therapy for metastatic renal cell carcinoma (mRCC) has evolved drastically, with agents targeting vascular endothelial growth factor (VEGF) and the mammalian target of rapamycin (mTOR) now representing a standard of care. The present paper is to review the current status of relevant clinica...

Full description

Bibliographic Details
Main Authors:	Sumanta K. Pal, Paulo Bergerot, Robert A. Figlin
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Asian Journal of Urology
Subjects:	Renal cell carcinoma Sdjuvant therapy Cytoreductive nephrectomy Vaccines Immunotherapy PD-1 Cabozantinib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388215000363

Similar Items

Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report
by: Takuya Nakagawa, et al.
Published: (2022-11-01)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
by: Hana Studentova, et al.
Published: (2023-07-01)

Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinib
by: Michikata Hayashida, et al.
Published: (2023-11-01)

Cytoreductive nephrectomy for metastatic renal cell carcinoma
by: Rajendra B Nerli
Published: (2013-01-01)

Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept
by: Claire Hao, et al.
Published: (2023-01-01)

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature
by: Hana Studentova, et al.
Published: (2022-08-01)

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
by: Brian M. Shinder, et al.
Published: (2017-05-01)

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature
by: Scott J. Dawsey, et al.
Published: (2021-05-01)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
by: Alex Renner, et al.
Published: (2019-03-01)

Severe Dyspnea due to Pulmonary Metastasis of Renal Cell Carcinoma: Is Cytoreductive Surgery of Value
by: Mohammad Kazem Moslemi, et al.
Published: (2010-09-01)

The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis
by: Boda Guo, et al.
Published: (2021-04-01)

Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
by: Amir F. Beirat, et al.
Published: (2023-02-01)

The impact of cytoreductive nephrectomy on survival outcomes in patients with metastatic renal cell carcinoma receiving immunotherapy: An evidence-based analysis of comparative outcomes
by: Kun-peng Li, et al.
Published: (2023-03-01)

Contemporary treatment of metastatic renal cell carcinoma
by: Igor Stukalin, et al.
Published: (2016-07-01)

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy
by: Zhao Zhang, et al.
Published: (2020-09-01)

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report
by: Mehmet A. Bilen, et al.
Published: (2021-02-01)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
by: Luigi Napolitano, et al.
Published: (2023-04-01)

Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis
by: Nessn Azawi, et al.
Published: (2024-03-01)

Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview
by: Valeria Internò, et al.
Published: (2021-04-01)

Renal cell carcinoma not otherwise specified: A case report in Indonesia
by: Hasan, et al.
Published: (2023-09-01)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
by: Michele Iuliani, et al.
Published: (2021-08-01)

New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01)

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
by: Laura Iisager, et al.
Published: (2024-02-01)

Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab
by: Hirotaka Fuchizawa, et al.
Published: (2021-09-01)

Giant Renal Cell Carcinoma Surgical Challenges and Life Expectancy: A Real-World Analysis of Serial Cases
by: Sawkar Vijay Pramod, et al.
Published: (2021-10-01)

Neoadjuvant nivolumab and cabozantinib in advanced renal cell carcinoma in a horseshoe kidney – how to achieve a safe and radical resection? a case report and review of the literature
by: Anezka Zemankova, et al.
Published: (2023-07-01)

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
by: Rathi N, et al.
Published: (2020-05-01)

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
by: Thomas Powles, et al.
Published: (2021-08-01)

Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma
by: Takashi Nakagawa, et al.
Published: (2022-07-01)

ExPert ConsEnsus on the management of Advanced clear-cell RenaL celL carcinoma: INDIAn Perspective (PEARL-INDIA)
by: Tarini Prasad Sahoo, et al.
Published: (2023-08-01)

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma
by: Amanda Nizam, et al.
Published: (2020-01-01)

Treatment Options for Renal Cell Carcinoma: Mechanisms and Outcomes
by: Benjamin Ptasienski, et al.
Published: (2023-06-01)

Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers
by: Igor Richter, et al.
Published: (2022-03-01)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
by: Alexandr Poprach, et al.
Published: (2020-10-01)

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma
by: Kan Wu, et al.
Published: (2020-12-01)

Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center
by: Kewei Chen, et al.
Published: (2023-06-01)

Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?
by: Stamatios Katsimperis, et al.
Published: (2022-12-01)

Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database
by: Yishan Zhang, et al.
Published: (2022-01-01)

Editorial: Case reports in renal cell carcinoma
by: Tony Z. Zhuang, et al.
Published: (2023-03-01)